- Business
- Beijing Tongrentang Co., Ltd. (600085.SS) engages in the research, development, production, distribution, and sale of traditional Chinese patent medicines and related healthcare products primarily in China and internationally. The company offers a wide range of dosage forms including pills, powders, wine preparations, capsules, and oral liquids targeting therapeutic areas such as cardiovascular conditions, gynecology, heat-clearing remedies, respiratory system disorders, nourishing and calming treatments, digestive system issues, pediatrics, wind-dispelling and dampness-removing formulas, orthopedics, five senses ailments, dermatology, psychological health, and food and wine products; it also provides complementary services like traditional Chinese medicine consultations, acupuncture, Tuina massage, Qigong exercise, dietary therapies, and herbal medicine brewing through its clinics and retail network. Founded in 1669 during the Qing Dynasty and headquartered in Beijing, the company operates manufacturing facilities and over 140 branches across 29 countries and regions, with a strong presence in Chinese-speaking markets and expanding global outreach via its Hong Kong-based group established in 2004. In recent developments, Beijing Tongrentang Technology, a related entity, formed a strategic partnership with Nisun International in October 2024 to supply traditional Chinese medicine materials, enhancing supply chain diversification; additionally, in January 2024, the company transferred equity in certain healthcare assets to Beijing Tong Ren Tang Healthcare Investment Co., Ltd., supporting ongoing mergers and acquisitions in the medical sector, while the group pursues further hospital acquisitions targeting five by 2028.